Euflexxa Injection Success Rates: What Clinical Trials and Patient Outcomes Reveal
The landmark FLEXX Trial, a double-blind randomized study of 588 patients with knee osteoarthritis, demonstrated that Euflexxa produced a median pain reduction of 53% from baseline at 26 weeks—compared to 38% for saline control. For the 32.5 million Americans living with osteoarthritis, these clinical outcomes represent a meaningful non-surgical treatment option. This article examines the […]
Euflexxa Injection Success Rates: What Clinical Trials and Patient Outcomes Reveal Read More »